PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...

In 2025, Hollywood star Eric Dane shared with the world that he had been diagnosed with a serious disorder that has left him ...

A Northwestern Medicine study has shed light on a critical molecular mechanism underlying amyotrophic lateral sclerosis (ALS) ...

The study will be carried out at up to 60 ALS treatment centres across Canada, the EU, the US, Israel and the UK.

In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...

Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...

Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic lateral sclerosis, or ALS, earlier from a blood sample, a study suggests. They ...

Using adaptive tools and following ALS kitchen safety strategies can make cooking and eating safer when living with ALS.

Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic ...

On November 17, 2025, Congressman Jason Crow introduced H.R. 6001, the Veterans with ALS Reporting Act. The purpose of this Act is to prioritize learning why disabled veterans are more likely than ...

The Muscular Dystrophy Association (MDA) today announced more than $2.7 million in new research grants to advance groundbreaking discoveries across multiple neuromuscular diseases, including ...

Using machine learning models, researchers have identified a potential way to diagnose amyotrophic lateral sclerosis earlier ...